Clinical Trials Browser

Phase 3 × Breast Neoplasms × Quality of Life × Clear all

NCT05670054 2023-01-04

Cyclin Dependant Kinase 4/6 (CDK4/6) Inhibitors as a Second Line Treatment in Metastatic Breast Cancer Patients

Phase 3 Unknown

Breast Neoplasms